Browsing publications by Dr Christopher Jones

Newcastle AuthorsTitleYearFull text
James Murray
Huw Thomas
Philip Berry
Suzanne Kyle
Dr Miranda Patterson
et al.
Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules2014
Dr James Hayden
Dr Christopher Jones
Professor Steven Clifford
Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis2012
Dr Christopher Jones
Dr Andrew Hughes
Prophylactic cranial irradiation (PCI) in extensive stage small cell lung cancer (ED-SCLC): a retrospective review of practice at the Northern Centre for Cancer Treatment2009
Dr Christopher Jones
Professor Ruth Plummer
PARP inhibitors and cancer therapy - early results and potential applications2008
Professor Ruth Plummer
Dr Christopher Jones
Professor Nicola Curtin
Professor Alan Boddy
Professor Herbie Newell
et al.
Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors2008
Dr Robert Thomas
Dr John Allen
Dr Christopher Jones
Applications of infrared thermography in medicine2005
Professor Ruth Plummer
Dr Christopher Jones
Lynsey Robson
Professor Alan Calvert
First in human phase I trial of the PARP inhibitor AG-014699 with temozolomide (TMZ) in patients (pts) with advanced solid tumors2005
Professor Ruth Plummer
Dr Christopher Jones
Professor Alan Boddy
Professor Alan Calvert
Professor Herbie Newell
et al.
Temozolomide pharmacodynamics in patients with metastatic melanoma: DNA damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-12005
Dr Christopher Jones
Dr Niamh Leonard
Pamela Chapman
Professor Sir John Burn
Identification of the familial cylindromatosis tumour-suppressor gene2000